# A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

> **NCT06369220** · NA · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 344 (actual)

## Conditions studied

- Chlamydia Trachomatis Infection
- Neisseria Gonorrhoeae Infection
- Mycoplasma Genitalium Infection

## Interventions

- **DIAGNOSTIC_TEST:** cobas® liat CT/NG/MG nucleic acid test
- **OTHER:** Standard of Care (SOC): Clinician's Standard Practice

## Key facts

- **NCT ID:** NCT06369220
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-29
- **Primary completion:** 2025-05-28
- **Final completion:** 2025-05-28
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2025-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06369220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06369220, "A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06369220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*